San Diego, CA, United States of America

Tie-Lin Wang

USPTO Granted Patents = 24 


 

Average Co-Inventor Count = 6.8

ph-index = 7

Forward Citations = 152(Granted Patents)


Location History:

  • San Diego, CA (US) (2001 - 2015)
  • Shanghai, CN (2016 - 2023)

Company Filing History:


Years Active: 2001-2023

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):

Title: The Innovative Journey of Tie-Lin Wang: A Pioneer in Pharmaceutical Patents

Introduction: Tie-Lin Wang is a distinguished inventor based in San Diego, CA, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 24 patents, Wang has established himself as an innovator dedicated to advancing therapeutic solutions through groundbreaking research and development.

Latest Patents: Among his latest patents are two noteworthy inventions. The first, titled "Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors," reveals a novel class of MDM2-p53 inhibitor compounds featuring an imidaxopyrolone structure. This invention specifically discloses compounds represented by formulas (I-1) and (I-2) and their pharmaceutically acceptable salts, offering potential pathways for cancer treatment. The second patent, "Crystal form of estrogen receptor inhibitor and preparation method therefor," introduces a crystal form of an estrogen receptor inhibitor, particularly focusing on crystal form A of a specific compound and its preparation method. This innovation holds promise for developing drugs aimed at treating breast cancer.

Career Highlights: Throughout his career, Tie-Lin Wang has made significant strides in the pharmaceutical industry. He has worked with prominent companies such as Exelixis, Inc. and Exelixis Patent Company LLC, where he contributed to various innovative projects that have advanced the field of drug development.

Collaborations: Wang's journey has also been marked by fruitful collaborations with esteemed colleagues. Notable among them are Richard Martin and Brenton Todd Flatt, with whom he has partnered on several projects, further enriching the landscape of pharmaceutical research and innovation.

Conclusion: Tie-Lin Wang continues to be a prolific inventor, driving advancements in the pharmaceutical sector with his inventive spirit. His latest patents not only showcase his commitment to addressing significant health challenges but also reflect his ongoing dedication to innovation in drug development. As Wang's career unfolds, he remains a pivotal figure within the realm of pharmaceutical inventions, inspiring future generations of inventors and researchers alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…